PGIM Jennison Health Sciences Fund - Class C (PHLCX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
11.84
-0.19 (-1.58%)
Jul 29, 2025, 4:00 PM EDT
-1.58%
Fund Assets1.36B
Expense Ratio1.96%
Min. Investment$1,000
Turnover79.00%
Dividend (ttm)5.25
Dividend Yield44.35%
Dividend Growth174.48%
Payout FrequencyAnnual
Ex-Dividend DateDec 20, 2024
Previous Close12.03
YTD Return-5.36%
1-Year Return-1.66%
5-Year Return45.22%
52-Week Low10.87
52-Week High19.91
Beta (5Y)0.58
Holdings45
Inception DateJun 30, 1999

About PHLCX

PGIM Jennison Health Sciences Fund – Class C is a mutual fund that primarily targets investments within the healthcare sector. Its main objective is to provide capital appreciation by investing in a diversified portfolio of companies spanning across medical and healthcare industries. This fund typically includes businesses involved in pharmaceuticals, biotechnology, medical devices, healthcare service providers, hospitals, managed care, and related fields, thereby covering a broad spectrum of the health sciences landscape. The portfolio is diversified by company size, with significant allocations to giant, large, medium, small, and micro-cap firms, reflecting a balanced approach to sector exposure. Managed by a team of experienced professionals, the fund seeks to capture growth opportunities arising from advancements in medical technology and evolving healthcare needs. As a sector-specific offering, it plays a specialized role in the financial market, appealing to investors looking for targeted exposure to healthcare trends and innovation. Performance returns and risk metrics are closely compared to health sector benchmarks and the broader market, providing insights into the fund’s competitive standing within its category.

Fund Family PGIM Investments
Category Health
Stock Exchange NASDAQ
Ticker Symbol PHLCX
Share Class Class C
Index S&P Composite 1500 Health Care TR

Performance

PHLCX had a total return of -1.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.87%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHLQXClass R60.77%
PHSZXClass Z0.86%
PHLAXClass A1.13%
PJHRXClass R1.48%

Top 10 Holdings

57.84% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY14.60%
Prudential Govt Money Mkt Fdn/a10.96%
Vertex Pharmaceuticals IncorporatedVRTX4.95%
argenx SEARGX4.85%
Neurocrine Biosciences, Inc.NBIX4.78%
AstraZeneca PLCAZN4.64%
Thermo Fisher Scientific Inc.TMO3.58%
Novo Nordisk A/SNVO3.50%
Alnylam Pharmaceuticals, Inc.ALNY3.15%
UnitedHealth Group IncorporatedUNH2.85%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 20, 2024$5.25148Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Dec 20, 2018$4.77761Dec 20, 2018
Full Dividend History